Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process

被引:40
作者
Yoshimatsu, M
Terasaki, Y
Sakashita, N
Kiyota, E
Sato, H
van der Laan, LJW
Takeya, M
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan
[2] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands
关键词
endotoxin; high-fat diet; hyperlipidaemia; MARCO; nonalcoholic steatohepatitis;
D O I
10.1111/j.0959-9673.2004.00401.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nonalcoholic steatohepatitis (NASH) is one of the life-threatening hepatic diseases; however, its pathogenesis is still unknown. To evaluate the causative role of hyperlipidaemia and high-fat diet, we compared C57BL/6 mice with inherited hyperlipidaemic model mice (LDLR-/- mice and ApoE(-/-) mice) fed a normal or a high-fat diet. LDLR-/- and ApoE(-/-) mice fed the normal diet showed significantly higher serum cholesterol level than that of C57BL/6 mice fed the high-fat diet. These mice, however, have shown neither significant elevation of serum alanine transaminase (ALT) level nor histopathologic features of steatohepatitis. High-fat diet groups of all three strains showed histopathological characteristics of steatohepatitis with elevated serum ALT levels and high expression of macrophage scavenger receptor MARCO mRNA in the liver. Semi-quantitative endotoxin analysis showed an elevated serum endotoxin level in the portal vein but not in the vena cava in ApoE(-/-) mice fed the high-fat diet. These results indicate that long-term feeding of a high-fat diet induces NASH, whereas hyperlipidaemia alone is not enough to induce NASH. Liver-restricted induction of MARCO in mice with high-fat diet and portal endotoxaemia in ApoE(-/-) mice fed the high-fat diet suggest the possible involvement of endotoxin in the pathogenesis of NASH.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 30 条
  • [1] ANTIBIOTICS PREVENT LIVER-INJURY IN RATS FOLLOWING LONG-TERM EXPOSURE TO ETHANOL
    ADACHI, Y
    MOORE, LE
    BRADFORD, BU
    GAO, WS
    THURMAN, RG
    [J]. GASTROENTEROLOGY, 1995, 108 (01) : 218 - 224
  • [2] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [3] Bergmeyer, 1983, METHODS ENZYMATIC AN, DOI DOI 10.1111/J.1432-1033.1989.TB14834.X
  • [4] BERGMEYER HU, 1978, CLIN CHEM, V24, P58
  • [5] BJARNASON I, 1984, LANCET, V1, P179
  • [6] Nonalcoholic steatohepatitis: Definition and pathology
    Brunt, EM
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (01) : 3 - 16
  • [7] NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
    Chitturi, S
    Abeygunasekera, S
    Farrell, GC
    Holmes-Walker, J
    Hui, JM
    Fung, C
    Karim, R
    Lin, R
    Samarasinghe, D
    Liddle, C
    Weltman, M
    George, J
    [J]. HEPATOLOGY, 2002, 35 (02) : 373 - 379
  • [8] Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
    Dixon, JB
    Bhathal, PS
    O'Brien, PE
    [J]. GASTROENTEROLOGY, 2001, 121 (01) : 91 - 100
  • [9] DUBOIS CM, 1993, EXP HEMATOL, V21, P303
  • [10] Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region
    Elomaa, O
    Sankala, M
    Pikkarainen, T
    Bergmann, U
    Tuuttila, A
    Raatikainen-Ahokas, A
    Sariola, H
    Tryggvason, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) : 4530 - 4538